Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 48

1.

Von Willebrand disease in the elderly: clinical perspectives.

Chapin J.

Clin Interv Aging. 2018 Aug 31;13:1531-1541. doi: 10.2147/CIA.S136931. eCollection 2018. Review.

2.

The Association between the Electronic Health Record and Patient-Reported Receipt of Tobacco Cessation Care in Hospitalized Veterans.

Kuperman EF, Chapin J, Grant KM, Vander Weg MW, Katz DA.

Jt Comm J Qual Patient Saf. 2018 May;44(5):304-306. doi: 10.1016/j.jcjq.2017.11.004. No abstract available.

PMID:
29759264
3.

Assessment of depression in epilepsy: the utility of common and disease-specific self-report depression measures.

Strober LB, Chapin J, Spirou A, Tesar G, Viguera A, Najm I, Busch RM.

Clin Neuropsychol. 2018 May;32(4):681-699. doi: 10.1080/13854046.2017.1400107. Epub 2017 Nov 22.

PMID:
29161968
4.

Bleeding Diatheses: Approach to the Patient Who Bleeds or Has Abnormal Coagulation.

Paddock M, Chapin J.

Prim Care. 2016 Dec;43(4):637-650. doi: 10.1016/j.pop.2016.07.009. Epub 2016 Oct 14. Review.

PMID:
27866582
5.

Outcomes in Patients With Hemophilia and von Willebrand Disease Undergoing Invasive or Surgical Procedures.

Chapin J, Bamme J, Hsu F, Christos P, DeSancho M.

Clin Appl Thromb Hemost. 2017 Mar;23(2):148-154. doi: 10.1177/1076029616658116. Epub 2016 Jul 19.

PMID:
27418638
6.

The safety of chronic antithrombotic therapy in patients with factor XI deficiency.

Chapin J, Klute K, Christos P, DeSancho M.

Br J Haematol. 2017 Nov;179(3):506-508. doi: 10.1111/bjh.14227. Epub 2016 Jul 8. No abstract available.

PMID:
27392111
7.

Gender and duration of disease differentiate responses to rituximab-dexamethasone therapy in adults with immune thrombocytopenia.

Chapin J, Lee CS, Zhang H, Zehnder JL, Bussel JB.

Am J Hematol. 2016 Sep;91(9):907-11. doi: 10.1002/ajh.24434. Epub 2016 Jun 20.

8.

The role of complement activation in thrombosis and hemolytic anemias.

Chapin J, Terry HS, Kleinert D, Laurence J.

Transfus Apher Sci. 2016 Apr;54(2):191-8. doi: 10.1016/j.transci.2016.04.008. Epub 2016 Apr 25. Review.

PMID:
27156108
9.

Clinical presentations, risk factors, treatment and outcomes in patients with splanchnic vein thrombosis: a single-center experience.

Klute K, DeFilippis EM, Shillingford K, Chapin J, DeSancho MT.

J Thromb Thrombolysis. 2016 Aug;42(2):267-71. doi: 10.1007/s11239-016-1337-4.

PMID:
26831481
10.

Reducing supervisee anxiety: Effects of a role induction intervention for clinical supervision.

Ellis MV, Hutman H, Chapin J.

J Couns Psychol. 2015 Oct;62(4):608-20. doi: 10.1037/cou0000099. Epub 2015 Jul 20.

PMID:
26191978
11.

Management strategies in patients with diffuse large B-cell lymphoma and severe haemophilia.

Rutherford SC, Martin P, Chapin J.

Haemophilia. 2015 Sep;21(5):e445-7. doi: 10.1111/hae.12741. Epub 2015 Jul 14. No abstract available.

PMID:
26178703
12.

Platelets and platelet-derived factor Va confer hemostatic competence in complete factor V deficiency.

Bouchard BA, Chapin J, Brummel-Ziedins KE, Durda P, Key NS, Tracy PB.

Blood. 2015 Jun 4;125(23):3647-50. doi: 10.1182/blood-2014-07-589580. Epub 2015 Apr 20.

13.

Adherence to guidelines for perioperative management of anticoagulation results in decreased bleeding complications: a single-centre experience.

DeSancho MT, Bardarova S, Chapin J.

Blood Coagul Fibrinolysis. 2015 Jun;26(4):426-9. doi: 10.1097/MBC.0000000000000275.

PMID:
25699609
14.

Hematopoietic transplant-associated thrombotic microangiopathy: case report and review of diagnosis and treatments.

Chapin J, Shore T, Forsberg P, Desman G, Van Besien K, Laurence J.

Clin Adv Hematol Oncol. 2014 Sep;12(9):565-73. Review.

PMID:
25654478
15.

Risk Factors and Treatment Strategies in Patients With Retinal Vascular Occlusions.

Chapin J, Carlson K, Christos PJ, DeSancho MT.

Clin Appl Thromb Hemost. 2015 Oct;21(7):672-7. doi: 10.1177/1076029613513320. Epub 2013 Dec 11.

PMID:
24335246
16.

Pulmonary embolism in a patient with congenital afibrinogenemia.

Chapin J, DeSancho M.

Haemophilia. 2013 Nov;19(6):e380-2. doi: 10.1111/hae.12234. Epub 2013 Jul 16. No abstract available.

PMID:
23855372
17.

Use of eculizumab in the treatment of a case of refractory, ADAMTS13-deficient thrombotic thrombocytopenic purpura: additional data and clinical follow-up.

Tsai E, Chapin J, Laurence JC, Tsai HM.

Br J Haematol. 2013 Aug;162(4):558-9. doi: 10.1111/bjh.12387. Epub 2013 May 21. No abstract available.

18.

Complement factor H mutations are present in ADAMTS13-deficient, ticlopidine-associated thrombotic microangiopathies.

Chapin J, Eyler S, Smith R, Tsai HM, Laurence J.

Blood. 2013 May 9;121(19):4012-3. doi: 10.1182/blood-2013-03-487694. No abstract available.

19.

Combined factor V and factor VIII deficiency: a report of a case, genetic analysis, and response to desmopressin acetate.

Chapin J, Cardi D, Gibb C, Laurence J.

Clin Adv Hematol Oncol. 2012 Jul;10(7):472-4. No abstract available.

PMID:
22895291
20.

Eculizumab in the treatment of refractory idiopathic thrombotic thrombocytopenic purpura.

Chapin J, Weksler B, Magro C, Laurence J.

Br J Haematol. 2012 Jun;157(6):772-4. doi: 10.1111/j.1365-2141.2012.09084.x. Epub 2012 Mar 13. No abstract available.

PMID:
22409250

Supplemental Content

Loading ...
Support Center